atai life sciences co-ceo says initial results from ele-101 show promise in treating depression
Published 2 months ago • 5.9K plays • Length 5:29Download video MP4
Download video MP3
Similar videos
-
7:07
atai life sciences outlines key milestones in psychedelic therapy for depression in 2023 and 2024
-
11:56
atai life sciences 'bringing innovation to mental healthcare and treatment addiction'
-
5:19
atai life sciences advances vls-01 for treatment-resistant depression
-
3:59
atai life sciences founder on using psychedelics to treat mental illness
-
33:00
florian brand talks of innovation in mental healthcare to tackle depression, anxiety and addiction
-
0:05
the stock of psychedelics giant atai is tumbling after a treatment failed to help patients |#shorts
-
5:07
end-of-life expert susan tolle on rolling out physicians orders for life-sustaining treatment
-
1:54
tetsuo kotani: three scenarios for asia's future
-
48:00
psychedelics for depression: the promise, risks, & costs - srinivas rao (mapping the mind 2019)
-
4:04
technology for data collection to combat covid-19 w/ dr. marcello ienca at eth zürich #datatalk
-
1:58
futurecast: technology that helps save lives | at&t & ericsson | at&t
-
15:22
stem cells & aging - eros lazzerini denchi, the scripps research institute
-
2:22
futurecast: the data trade-off and the social equation | at&t & ericsson | at&t
-
1:09:21
charles casto: "how can japan safely restart its nuclear energy program post-fukushima?"
-
23:48
valio | food solutions trend webinar 2019
-
1:43
healthy aging - gi: digestive health of the future: stem cells
-
6:48
atai life science founder, christian angermayer, talks about his psilocybin mushroom use
-
27:21
q&a panel | better together 2019 edtalk: math for all students